Abstract
Cysteine cathepsins are lysosomal cysteine proteases that are involved in a number of important biological processes, including intracellular protein turnover, propeptide and prohormone processing, apoptosis, bone remodelling, and reproduction. In cancer, the cathepsins have been linked to extracellular matrix remodelling and to the promotion of tumour cell motility, invasion, angiogenesis and metastasis, resulting in poor outcome of the disease. The levels of cathepsins as well as of their endogenous inhibitor cystatins in clinical samples have been suggested as potential biomarkers, and this chapter is focused on their role to predict the diagnosis, risk of recurrence and death, and response to therapy in patients with cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Lah, T.T., Obermajer, N., Alonso, M.B.D., Kos, J. (2008). Cysteine Cathepsins and Cystatins as Cancer Biomarkers. In: Edwards, D., Høyer-Hansen, G., Blasi, F., Sloane, B.F. (eds) The Cancer Degradome. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69057-5_29
Download citation
DOI: https://doi.org/10.1007/978-0-387-69057-5_29
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69056-8
Online ISBN: 978-0-387-69057-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)